Literature DB >> 22604514

Status of memory loss.

Parameswaran Mahadeva Iyer1, Joan Moroney, Gerard Mullins, Michael Farrell, Norman Delanty.   

Abstract

A 72-year-old woman presented with first onset of seizure with no prior history of cognitive dysfunction. EEG revealed focal non-convulsive status epilepticus. MRI brain showed a left temporal non-enhancing lesion. Temporal pole biopsy showed acute neuronal necrosis and astrocyte hyperplasia together with extensive amyloid plaques and neurofibrillary tangles. Perivascular oligodendroglial hyperplasia was present. Postmortem examination revealed extensive plaque and tangle disease. Perivascular oligodendroglial hyperplasia was limited to the left temporal area. The presence of focal perivascular oligodendroglial hyperplasia in the left temporal cortex, combined with extensive plaque and tangle disease may have contributed to the focal status epilepticus in this patient. Although the presence of focal perivascular oligodendroglial hyperplasia has been reported in cases of temporal lobe epilepsy, it has not been reported as a cause of seizure in patients with Alzheimer's disease previously. Further studies for clinical-pathologic correlation would be required to confirm this hypothesis.

Entities:  

Mesh:

Year:  2012        PMID: 22604514      PMCID: PMC3339172          DOI: 10.1136/bcr.11.2011.5267

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  3 in total

1.  Alzheimer's disease underlies some cases of complex partial status epilepticus.

Authors:  C Armon; G W Peterson; B H Liwnicz
Journal:  J Clin Neurophysiol       Date:  2000-09       Impact factor: 2.177

2.  Perivascular clustering in temporal lobe epilepsy: oligodendroglial cells of unknown function.

Authors:  Burkhard S Kasper; Werner Paulus
Journal:  Acta Neuropathol       Date:  2004-10-08       Impact factor: 17.088

3.  Seizures in Alzheimer's disease: clinicopathologic study.

Authors:  M F Mendez; P Catanzaro; R C Doss; R ARguello; W H Frey
Journal:  J Geriatr Psychiatry Neurol       Date:  1994 Oct-Dec       Impact factor: 2.680

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.